Zeba M. Khan

Director/Board Member at International Society for Pharmacoeconomics & Outcomes Rsch

Consumer Services

Commercial Services

Profile

Zeba M.
Khan is currently working as the Treasurer & Director at the International Society for Pharmacoeconomics & Outcomes Research.
Prior to this, Dr. Khan completed an undergraduate degree at the University of Utah and graduate and doctorate degrees at The University of Texas at Austin.

Zeba M. Khan active positions

Companies	Position	Start
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Director/Board Member	-

All active positions of Zeba M. Khan

Training of Zeba M. Khan

University of Utah	Undergraduate Degree
The University of Texas at Austin	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Zeba M. Khan's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
International Society for Pharmacoeconomics & Outcomes Rsch International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries.	Commercial Services